Learn More
Medchemexpress LLC [4-[[5-chloro-4-(methylamino)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino]-3-methoxyphenyl]-4-morpholinyl- | 1700693-08-8 | MFCD29472241 | 98.0% | 416.86 g/mol | C19H21ClN6O3 | 10 MG

Supplier: Medchemexpress LLC HY1693610MG
JH-II-127 is an orally active, highly potent, selective, and brain-permeable inhibitor of leucine-rich repeat kinase 2 (LRRK2) used in preclinical research to probe LRRK2 signaling and Parkinson's disease models. It shows low-nanomolar activity against wild-type and mutant LRRK2 and has characterized solubility and storage profiles for in vitro and in vivo studies.
- Highly potent LRRK2 inhibition (low-nanomolar IC50 values).
- Selective activity against wild-type and mutant LRRK2 variants.
- Brain permeable, suitable for central nervous system studies.
- High purity solid with defined storage conditions for stability.
- Documented solubility protocols for in vitro and in vivo use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.